1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 1,267 results.

Thumbnail for Primary Central Nervous System Lymphoma in Latin America: Real-World Clinicopathological Characteristics and Survival Outcomes From a National Reference Center

ABCL - 095

Primary Central Nervous System Lymphoma in Latin America: Real-World Clinicopathological Characteristics and Survival Outcomes From a National Reference Center

Amairani Carpintero Diaz

Poster Presenter: Amairani Carpintero Diaz

ABCL - 100

Comparative Pharmacovigilance of CD20-Directed Bispecific Antibodies in B-Cell Lymphoma: A FAERS Observational Study

Edward Mwarangu

Poster Presenter: Edward Mwarangu

$Thumbnail for Cellular Kinetics, Efficacy, and Safety of Zamtocabtagene Autoleucel, a Tandem CD20/CD19-Directed CAR T-Cell Therapy, vs R-GemOx in Patients With Relapsed/Refractory LBCL (DALY 2-EU Study)$

ABCL - 1001

Cellular Kinetics, Efficacy, and Safety of Zamtocabtagene Autoleucel, a Tandem CD20/CD19-Directed CAR T-Cell Therapy, vs R-GemOx in Patients With Relapsed/Refractory LBCL (DALY 2-EU Study)

Nirav Shah

Poster Presenter: Nirav Shah

$Thumbnail for Long-Term Outcomes of Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma: A Systematic Review of Efficacy, Survival, Minimal Residual Disease, and Safety$

ABCL - 1004

Long-Term Outcomes of Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma: A Systematic Review of Efficacy, Survival, Minimal Residual Disease, and Safety

Sai Harsha Yendluri

Poster Presenter: Sai Harsha Yendluri

$Thumbnail for Comparative Real-World Efficacy and Safety of 4-1BB-based (Liso-Cel/Tisa-Cel) vs CD28-Construct Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis$